COMPASS Pathways plc (CMPS)

8,25 -0,23 (-2,71%) Alla chiusura: 04:00PM EDT

COMPASS Pathways plc

33 Broadwick Street
London W1F 0DQ
United Kingdom
44 71 6676 6461
https://compasspathways.com

Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 186

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Kabir Kumar Nath M.A., M.B.A.	CEO & Director	1,31M	N/D	1964
Mr. Matthew Allen Owens	General Counsel & Chief Legal Officer	684,51k	N/D	1977
Dr. Guy Goodwin	Chief Medical Officer	567k	N/D	1948
Ms. Teri Loxam M.B.A.	CFO, Principal Financial Officer & Principal Accounting Officer	N/D	N/D	1973
Dr. Greg Ryslik Ph.D.	Chief Technology Officer	N/D	N/D	N/D
Mr. Stephen D. Schultz	Senior Vice President of Investor Relations	N/D	N/D	N/D
Mr. Christopher Williams	Chief Communications Officer	N/D	N/D	N/D
Ms. Anne Benedict	Chief People Officer	N/D	N/D	N/D
Mr. Lars Christian Wilde	Senior Advisor	N/D	N/D	1985
Mr. Trevor Mill	Chief Development Officer	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Governance aziendale

L'ISS Governance QualityScore di COMPASS Pathways plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.